CAS 2449301-27-1

GSK2643943A

CAS : 2449301-27-1

Formule : C₁₇H₁₂FN₃

Degré de pureté : 98%

Masse moléculaire : 277.2957

Ref: IN-DA01V4YB

GSK2643943A

CAS : 2449301-27-1

GSK2643943A

Degré de pureté : ≥95%

Masse moléculaire : 277.3g/mol

Ref: 54-BUP05269

GSK2643943A

CAS : 2449301-27-1

GSK2643943A is an investigational drug, which is a product of GlaxoSmithKline's extensive research efforts. It is a small molecule inhibitor targeting specific cellular pathways involved in tumor growth and proliferation. This compound is designed to selectively inhibit kinase signaling, a process critical for the survival and metastasis of cancer cells. By disrupting these pathways, GSK2643943A aims to impede cancer progression, offering a potential new avenue for therapeutic intervention in oncology.

Formule : C₁₇H₁₂FN₃

Degré de pureté : Min. 95%

Masse moléculaire : 277.29 g/mol

Ref: 3D-ZXD30127

GSK2643943A

CAS : 2449301-27-1

GSK2643943A is a deubiquitylating enzyme (DUB) inhibitor, with an IC 50 of 160 nM for USP20/Ub-Rho. GSK2643943A has anti-tumor efficacy.

Formule : C₁₇H₁₂FN₃

Degré de pureté : 97.09%

Couleur et forme : Solid

Masse moléculaire : 277.3

Ref: TM-T11485